K-Beauty Market Briefing — 2026-08-14

Original English analysis for global buyers. Source articles are linked; summaries are newly written, not excerpted.

investment

Global capital is buying K-beauty's factories, not its brands

Macquarie PE was selected as preferred bidder for a roughly KRW 300 billion deal covering about 70% of color-cosmetics ODM Hwasung Cosmetics and all of foundation specialist Now Cos, whose clients include the Estée Lauder group. Deal watchers read it as a shift in K-beauty investment from brand equity to manufacturing infrastructure — owning the capacity that many global brands' export growth runs through.

Buyer takeaway: Buyers sourcing private-label or indie-brand products made at Korean ODMs should expect consolidation to firm up pricing and prioritize large committed orders, so locking multi-season manufacturing slots before ownership changes close is the defensive move.

Source: Financial News (Korean)

regulation

Korea takes the counterfeit fight to 70 countries

Korean authorities removed more than 20,000 counterfeit beauty products in the first half of 2026 after 36,000 in 2025, and will register government-certified trademarks across more than 70 countries from October, enabling investigations and customs interventions abroad. Formal cooperation with e-commerce platforms expanded from six to nine partners, adding TikTok Shop, Temu and Tokopedia.

Buyer takeaway: Buyers sourcing through secondary distributors or marketplaces should tighten provenance checks now, because stepped-up enforcement means counterfeit or gray-market K-beauty stock will increasingly be seized at customs — with the importer of record carrying the loss.

Source: Global Cosmetics News (Korean)

regulation

Saudi Arabia outlaws the syringe aesthetic from 2027

Saudi Arabia's SFDA will ban externally applied cosmetics in syringe-style packaging from 1 January 2027, with compliance required by end-2026; ampoules and vials stay legal but must carry Arabic-and-English warnings that the product must not be injected, and marketing may not imply injection. The rule directly affects the syringe-format ampoules and PDRN serums popular in Korean skincare.

Buyer takeaway: GCC buyers should audit their K-beauty assortments for syringe-format packaging this quarter and push suppliers for repack timelines, because stock that lands after the deadline in old packaging is unsellable in the Saudi market.

Source: Global Cosmetics News (Korean)

About AnD KBeauty

This briefing is researched and written by AnD KBeauty, a Seoul-based K-beauty B2B wholesale supplier for small and mid-size retailers in the US, EU/UK, the Middle East and Southeast Asia. We publish open MOQs, lead times and compliance guides with no login wall, and consolidate mixed-brand orders from 30-100 units per SKU into one shipment from Korea.

Browse the open catalog · Request a wholesale quote · All briefings